Home » Topics » Regulatory » Patents

Patents
RSS

VEGF and FGF receptor TK inhibitors from Zeneca

Jan. 20, 1998

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

MS&D reveals new class of antimigraine agents

Jan. 20, 1998

Lilly discloses new agents for influenza

Jan. 20, 1998

Novel semisynthetic macrolides prepared at Abbott

Jan. 20, 1998

Lilly discloses novel compounds for influenza

Jan. 19, 1998

Lilly reports new benzothiophenes for gynecological and other disorders

Jan. 19, 1998

Novartis reveals agents for atherosclerosis and chronic inflammation

Jan. 19, 1998

Merck & Co. claims carbapenems active against methicillin-resistant staphylococci

Jan. 19, 1998

Peptide HIV protease inhibitors claimed by Merck & Co.

Jan. 19, 1998

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...